We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £376,230
som saa is a unique cocktail bar and restaurant located in Spitalfields, London. It serves high quality regional Thai cuisines made with uncompromising flavours. som saa has more than 27,000 followers on Instagram and carries a loyal customer following. In 2016, som saa became the Restaurant of the Year sponsored by The London Restaurant Festival. It is planning to open a second restaurant in Central London. Approximately 32.5% of the proceeds will be used for building and direct works; 20% will be used for kitchen design, building, and extraction; 14% will be used for professional fees; 5% for bar installation; and 28.5% other opening costs.

Pitch Rated

61%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £253,633
Big Night is an online food delivery service that partners with selected independent food vendors to deliver exceptional meals to customers at home, in their office or wherever they choose. The company asserts that 61% of non-millennials find delivery overall frustrating. Big Night aims to change this scenario. It has signed on ten notable restaurants and has ten more in the immediate pipeline. Onboarded restaurants include Two Lights, Luca, The Laughing Heart, Sager + Wilde, Royale, Levan, AngloThai, Legare and Mangal2. Over 4,000 people have ordered via Big Night since its launch. The company will use 25% of the investment for operations, 25% for marketing, and 50% to improve the Big Night platform.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,168
Market Halls (MH) takes unloved public spaces and transforms them into destinations for all-day drinking and dining. MH claims to offer something for everyone, taking visitors seamlessly from breakfast through to late-night snacks. It argues that it has established three venues in Fulham, Victoria and the West End that have attracted crowds in excess of 1.04 million in 2019. MH asserts that it received a Net Promoter Score (NPS) of 62, generated £15 million in revenue in 2020, and has featured in publications such as The Telegraph, The Guardian and Independent. MH also stresses that it has a ‘Best in Class’ retention rate of 80% repeat business. It states it will use the investment to scale up its business with a new identity, new gold-dust venues and an improved customer offering.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £787,240
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £891,790
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.

Pitch Rated

59%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,753,067
Gravitricity is an energy technology company. The company uses winches to raise a heavyweight to the top of a vertical shaft to store electricity in the form of potential energy when there is excess energy on the grid. It then lowers it when required with the winch motors running as generators to transfer energy back to users on the grid. Gravitricity argues that the system can be charged and discharged multiple times a day for over 25 years. The company has built a 250kW concept demo in Edinburgh. It aims to become a contender in the energy storage market that is set to be worth $620 billion by 2040. The company has received interest from operating mines, grid companies, EV charging stations and solar developers for its technology. It is also investigating project sites in UK, Europe, the USA and South Africa. It will use the investment to complete the concept and detailed design for its prototype, develop its commercial projects portfolio, and protect its Intellectual Property (IP).

Pitch Rated

58%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £2,124,008
Established as a trusted brand since 2017, YPP provides high-quality and bespoke printed products to the public, private, and third sectors. In 2019, YPP launched a site Customgifts.co.uk for year-round gifting, following the success of Santa Sacks, a B2C Christmas brand in 2018. Within six months, they have achieved sales of over £300,000, hold licenses with many world-renowned brands with the likes of Harry Potter, Batman, Loony Tunes and Elf, and a variety of top-flight football clubs. The Custom Gifts site has already processed over 14,000 orders with more than 13,000 customers joining their database. The funds raised will be used for online marketing, new product development, and hiring of new staff.

Pitch Rated

58%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £404,490
Greenwall Environmental Group is a company engaged in making devices that can minimise non-biodegradable waste. It argues that asbestos remains the largest occupational killer in the UK today. Its product, Asbestosprobe, aims to change this situation. The company asserts that Asbestoprobe is arguably the world's first handheld analyser specifically designed to detect asbestos in real-time. It argues that current methods of detecting and recording the presence of asbestos are costly, invasive and slow. Asbestoprobe uses a point-and-click approach utilising NIR Spectroscopy and Artificial Intelligence (AI) to analyse the presence of asbestos in two minutes via the Asbestoprobe App. Greenwall plans to provide an annual software licensing model which grows through recurring revenue year on year. It endeavours to be a segment leader in the projected $1 billion global asbestos management market. The company will use the investment to grow its business across different verticals.

Pitch Rated

58%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £253,017
Celtic Renewables (CR) converts residual by-products from Scottish Whisky production into high-value, low-carbon sustainable chemical and biofuel products using its patented Acetone-Butanol-Ethanol (ABE) fermentation process. CR asserts that the end products, Acetone, Butanol, Ethanol & high-grade animal feed, play an important role in daily human lives. The company argues that these are potential applicants in industries such as pharmaceuticals, cosmetics, food production, hygiene products & advanced sustainable biofuels. CR states that the downstream markets for ABE biochemicals would be worth over £130 billion by 2025. It aims to be a leading contender in this segment. It also endeavours to replicate its ABE technology in global markets. CR has been named the 'Most Innovative Biotech SME' in Europe. The company will use the investment to bring its first industrial-scale plant into full operation by Q1 of 2021 and capitalise on commercial opportunities.

Pitch Rated

58%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £3,576,901
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph